.

Make Better Decisions

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Argus Health
US Department of Justice
Citi
QuintilesIMS
AstraZeneca
Covington
Queensland Health
Teva
Chinese Patent Office

Generated: November 24, 2017

DrugPatentWatch Database Preview

HYDROCODONE BITARTRATE AND HOMATROPINE METHYLBROMIDE Drug Profile

« Back to Dashboard

What is the patent landscape for Hydrocodone Bitartrate And Homatropine Methylbromide, and when can generic versions of Hydrocodone Bitartrate And Homatropine Methylbromide launch?

Hydrocodone Bitartrate And Homatropine Methylbromide is a drug marketed by Wockhardt, Hi Tech Pharma, Actavis Mid Atlantic, Paddock Llc, Novel Labs Inc, Bio-pharm Inc, Ivax Sub Teva Pharms, and Abhai Llc. and is included in eight NDAs.

The generic ingredient in HYDROCODONE BITARTRATE AND HOMATROPINE METHYLBROMIDE is homatropine methylbromide; hydrocodone bitartrate. There are five drug master file entries for this compound. Fourteen suppliers are listed for this compound. Additional details are available on the homatropine methylbromide; hydrocodone bitartrate profile page.

Summary for HYDROCODONE BITARTRATE AND HOMATROPINE METHYLBROMIDE

Pharmacology for HYDROCODONE BITARTRATE AND HOMATROPINE METHYLBROMIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Wockhardt
HYDROCODONE BITARTRATE AND HOMATROPINE METHYLBROMIDE
homatropine methylbromide; hydrocodone bitartrate
SYRUP;ORAL088008-001Mar 3, 1983AARXNoNo► Subscribe► Subscribe► Subscribe
Ivax Sub Teva Pharms
HYDROCODONE BITARTRATE AND HOMATROPINE METHYLBROMIDE
homatropine methylbromide; hydrocodone bitartrate
SYRUP;ORAL040285-001Jul 19, 1999DISCNNoNo► Subscribe► Subscribe► Subscribe
Paddock Llc
HYDROCODONE BITARTRATE AND HOMATROPINE METHYLBROMIDE
homatropine methylbromide; hydrocodone bitartrate
SYRUP;ORAL205731-001Feb 15, 2017AARXNoNo► Subscribe► Subscribe► Subscribe
Abhai Llc
HYDROCODONE BITARTRATE AND HOMATROPINE METHYLBROMIDE
homatropine methylbromide; hydrocodone bitartrate
SYRUP;ORAL207487-001Feb 21, 2017AARXNoNo► Subscribe► Subscribe► Subscribe
Hi Tech Pharma
HYDROCODONE BITARTRATE AND HOMATROPINE METHYLBROMIDE
homatropine methylbromide; hydrocodone bitartrate
SYRUP;ORAL040613-001Feb 8, 2008AARXNoYes► Subscribe► Subscribe► Subscribe
Actavis Mid Atlantic
HYDROCODONE BITARTRATE AND HOMATROPINE METHYLBROMIDE
homatropine methylbromide; hydrocodone bitartrate
SYRUP;ORAL088017-001Jul 5, 1983AARXNoNo► Subscribe► Subscribe► Subscribe
Bio-pharm Inc
HYDROCODONE BITARTRATE AND HOMATROPINE METHYLBROMIDE
homatropine methylbromide; hydrocodone bitartrate
SYRUP;ORAL204765-001Mar 6, 2017AARXNoNo► Subscribe► Subscribe► Subscribe
Novel Labs Inc
HYDROCODONE BITARTRATE AND HOMATROPINE METHYLBROMIDE
homatropine methylbromide; hydrocodone bitartrate
SYRUP;ORAL203535-001Feb 13, 2017AARXNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Healthtrust
Chinese Patent Office
Citi
Moodys
Johnson and Johnson
McKesson
Accenture
Cipla
Julphar
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot